Outset Medical (OM) Free Cash Flow (2019 - 2026)
Outset Medical's (OM) quarterly Free Cash Flow came in at -$12.9 million in Q1 2026, up 49.94% year-on-year from -$8.6 million in Q1 2025, and down 32.48% on a QoQ basis from -$9.7 million in Q4 2025.
Outset Medical (OM) Free Cash Flow (2019 - 2026) Analysis & Trends
Outset Medical (OM) has 8 years of Free Cash Flow data on file, last reported at -$12.9 million in Q1 2026.
- On a quarterly basis, Free Cash Flow rose 49.94% year-over-year to -$12.9 million in Q1 2026; TTM through Mar 2026 was -$34.2 million, a 64.39% increase from a year earlier, with the FY2025 full-year figure at -$47.1 million, up 59.49% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$12.9 million, down from -$9.7 million in the prior quarter.
- Over the last five years, Free Cash Flow for OM reached as high as -$4.8 million in Q2 2025 and fell as low as -$45.9 million in Q1 2024.
- Historically, Free Cash Flow has averaged -$26.7 million across 5 years, with a median of -$29.0 million in 2023.
- Across the five-year window, Free Cash Flow tumbled 35.18% in 2022 and surged 85.78% in 2025, its largest moves.
- Year by year, Free Cash Flow stood at -$34.1 million in 2022, then jumped by 34.89% to -$22.2 million in 2023, then increased by 29.55% to -$15.6 million in 2024, then jumped by 37.74% to -$9.7 million in 2025, then sank by 32.48% to -$12.9 million in 2026.
- Per Business Quant data, the three most recent Free Cash Flow figures were -$12.9 million in Q1 2026, -$9.7 million in Q4 2025, and -$6.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.39 Bn | 175.10 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.87 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 108.59 Bn | 99.37 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 68.22 Bn | 66.77 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 47.59 Bn | 43.92 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Dexcom | 28.58 Bn | 27.46 Bn | 750.30 Mn | 449.00 Mn |
| 7 | GE HealthCare Technologies | 28.48 Bn | 26.20 Bn | 1.98 Bn | 112.00 Mn |
| 8 | Smith & Nephew | 26.96 Bn | 26.39 Bn | - | - |
| 9 | Koninklijke Philips | 25.47 Bn | 22.34 Bn | 2.07 Bn | 305.56 Mn |
| 10 | Outset Medical | 77,625.92 | -286.57 Mn | 12.10 Mn | -12.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.91 Mn |
| Mar 31, 2026 | -12.91 Mn |
| Dec 31, 2025 | -9.74 Mn |
| Dec 31, 2025 | -9.74 Mn |
| Sep 30, 2025 | -6.79 Mn |
| Sep 30, 2025 | -6.79 Mn |
| Jun 30, 2025 | -4.80 Mn |
| Jun 30, 2025 | -4.80 Mn |
| Mar 31, 2025 | -25.79 Mn |
| Mar 31, 2025 | -25.79 Mn |
| Dec 31, 2024 | -15.65 Mn |
| Dec 31, 2024 | -15.65 Mn |
| Sep 30, 2024 | -20.96 Mn |
| Sep 30, 2024 | -20.96 Mn |
| Jun 30, 2024 | -33.77 Mn |
| Jun 30, 2024 | -33.77 Mn |
| Mar 31, 2024 | -45.95 Mn |
| Mar 31, 2024 | -45.95 Mn |
| Dec 31, 2023 | -22.21 Mn |
| Dec 31, 2023 | -22.21 Mn |